# Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

> **NCT04564716** · PHASE3 · UNKNOWN · sponsor: **Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation** · enrollment: 100 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Gam-COVID-Vac
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04564716
- **Lead sponsor:** Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-28
- **Primary completion:** 2021-03-28
- **Final completion:** 2021-04-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04564716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04564716, "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04564716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*